Recent evidence remains mixed: a meta-analysis of randomized trials reported a slight increase in pancreatitis risk among GLP-1 RA users, whereas a large real-world analysis found no excess risk in a comorbidity-free population [29, 30]
Maintaining your results means adopting healthy habits and potentially continuing with a long-term support plan
With heterogeneous evidence of the cardiovascular benefit, mortality, and potential risks of intensive glycemic control reported in several recent clinical trials, achieving good blood glucose control without increasing cardiovascular risk factors such as hypoglycemia and body weight gain is becoming more important [3,4,5,6,7]
Over 1,000mg of total electrolytes
doi: 10.1038/s41574-024-01047-y, 43
10.1016/j.bbr.2024.115246 237 KieckaA.SzczepanikM